Literature DB >> 18209503

How early do airway inflammation and remodeling occur?

Andrew Bush1.   

Abstract

Eosinophilic airway inflammation and structural airway changes are present in school age asthmatics. When these changes occur, and their relationship, are controversial. Some structural airway changes, up-regulation of collagens 1 and 111, and increased distance between alveolar tethering points, may be antenatal, and independent of inflammation. We have established that there is no eosinophilic inflammation or reticular basement membrane thickening in wheezing infants median age one year; but by age three years, both are present. This accords with cohort studies, showing that children who become persistent wheezers have a drop in lung function in the pre-school years. Thereafter, lung function tracks into middle age, so the preschool years represent window during which an intervention might have long term benefit. Supportive are measurements in blood and bronchoalveolar lavage fluid, implicating the neutrophil as the key inflammatory cell in early wheeze. Models of the pathophysiology of asthma include (1) that eosinophilic inflammation is the primary event, and leads to remodelling as a secondary event, which itself results in progressive airflow obstruction (the least likely model); (2) eosinophilic inflammation is the primary event, but remodelling is protective, preventing worsening AHR. It should be noted that these first two are not mutually exclusive; rbm thickening may be protective, but other components of remodeling, for example increased ASM, may have adverse effects; (3) eosinophilic inflammation and airway remodelling are parallel processes, driven by some underlying 'asthma factor'; and (4) the primary abnormality is not airway inflammation, but some form of disordered airway repair.

Entities:  

Mesh:

Year:  2008        PMID: 18209503     DOI: 10.2332/allergolint.R-07-155

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  11 in total

1.  Serum Clara cell protein and atopic phenotype in children up to 2 years of age.

Authors:  Nevenka Ilic; Natasa Mihailovic
Journal:  J Clin Lab Anal       Date:  2017-02-01       Impact factor: 2.352

Review 2.  Epidemiology of stress and asthma: from constricting communities and fragile families to epigenetics.

Authors:  Rosalind J Wright
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

Review 3.  Airway remodeling: a potential therapeutic target in asthma.

Authors:  Wei-Xi Zhang; Chang-Chong Li
Journal:  World J Pediatr       Date:  2011-05-15       Impact factor: 2.764

Review 4.  Are We Meeting the Promise of Endotypes and Precision Medicine in Asthma?

Authors:  Anuradha Ray; Matthew Camiolo; Anne Fitzpatrick; Marc Gauthier; Sally E Wenzel
Journal:  Physiol Rev       Date:  2020-01-09       Impact factor: 37.312

Review 5.  Perinatal stress and early life programming of lung structure and function.

Authors:  Rosalind J Wright
Journal:  Biol Psychol       Date:  2010-01-18       Impact factor: 3.251

Review 6.  The origins of asthma and chronic obstructive pulmonary disease in early life.

Authors:  Fernando D Martinez
Journal:  Proc Am Thorac Soc       Date:  2009-05-01

Review 7.  Severe asthma in children.

Authors:  Theresa W Guilbert; Leonard B Bacharier; Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Sep-Oct

8.  Pharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues.

Authors:  Paolo Montuschi
Journal:  Front Pharmacol       Date:  2011-07-14       Impact factor: 5.810

Review 9.  Chronic inflammation and asthma.

Authors:  Jenna R Murdoch; Clare M Lloyd
Journal:  Mutat Res       Date:  2009-09-19       Impact factor: 2.433

10.  Predictive Value of the TRACK Questionnaire as a Measure of Asthma Control in Preschool Aged Children.

Authors:  Ozge Yilmaz; Ahmet Turkeli; Sebnem Sahin; Hasan Yuksel
Journal:  Allergy Asthma Immunol Res       Date:  2014-02-05       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.